Environmental Sustainability: Embedding Responsible Manufacturing Practices across the Pharmaceutical Value Chain

As a science-based health industry, pharmaceutical professionals are always working towards improving human health and well-being. The environmental protection needed as a result of climate emergencies are an essential factor in helping to improve the health and lives of patients.

With increasing international support, the climate emergency is in motion and concerns over water consumption, pharmaceuticals in the environment (PiE), antimicrobial resistance (AMR) and the industry's reliance on fossil fuels have put pharmaceutical manufacturing practices under the spotlight as discussions around the circular economy and carbon targets dominate sustainability milestones outside of the industry.

While the drive towards circularity will offer growth opportunities, natural resources efficiencies and the protection of future medicines supply, in one of the worlds most regulated industries, the pharmaceutical industry's approach to circularity is met with several challenges including the speed of transition to new innovative technologies and the supply chain. 

• Addressing climate emergency's effect on public health
• Reuse-Recycle- what role can waste management play in improving secondary raw materials?
• Aligning goals and collaboration across the value chain
• Standardizing Sustainability: Industry progresses on setting sustainability standards